A panel including an expert neurologist give their perspectives on overall management of progressive multiple sclerosis and the impact of COVID-19.
NeuroVoices: Michael Sughrue, MD, on the Future of Brain Mapping and Utilizing Advanced Technology
The Mobile Stroke Unit Paradigm Shift for EMS: Thomas Topley
American Stroke Association Publishes Updated Guidance for Intracerebral Hemorrhage
FDA Accepts New Drug Application for Intranasal Zavegepant to Treat Acute Migraine